Company / Depreciation & Amortization
Pacira BioSciences, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$91.0M
FY2025
5-year range
$19.6M / $91.5M
FY2021-FY2025
Trend
+15.5%
vs FY2024
Sector context
#22 of 163
Health Care
What the data says
Pacira BioSciences, Inc.'s depreciation & amortization of $91M is higher than 87% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $11M in FY2017 to $92M in FY2022.
Based on SEC 10-K filings.
$91M in FY2025 with a 5-year CAGR of +47.2%. Top quartile in the Health Care sector.
Increased from $76M to $91M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- +47.2%
- 10-Year CAGR
- -
Sector benchmark
-58.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +47.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 15.5% year-over-year.
- Ranks #22 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.0M | +15.5% |
| FY2024 | $78.8M | +4.2% |
| FY2023 | $75.6M | -17.4% |
| FY2022 | $91.5M | +367.4% |
| FY2021 | $19.6M | +48.7% |
| FY2020 | $13.2M | -4.8% |
| FY2019 | $13.8M | +7.1% |
| FY2018 | $12.9M | +12.6% |
| FY2017 | $11.5M | -11.2% |
| FY2016 | $12.9M | +12.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026